Model
Edge
Moonlake Immunotherapeutics
0001920545
Filing Type
4
Filing Date
10/8/2025
Updated
10/9/25, 7:01 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership